Table 3.
Demographics, blood, and CT comparisons for COPD patients with or without PH
| Variable | COPD-PH | Number | Non-PH | Number | P-value |
|---|---|---|---|---|---|
| Age (years) | 71±10 | 56 | 69±10 | 165 | 0.23 |
| Women, n (%) | 12 (21.4%) | 34 (20.6%) | 0.90 | ||
| CRP (mg/L)* | 26.2±4.7 | 54 | 35.6±4.6 | 158 | 0.16 |
| Blood sugar (mmol/L)* | 6.22±0.41 | 54 | 5.55±0.12 | 159 | 0.13 |
| TG (mmol/L)* | 0.99±0.07 | 55 | 1.15±0.05 | 160 | 0.08 |
| MPA diameter (mm) | 32.1±6.2 | 56 | 27.5±4.3 | 165 | P<0.001 |
| RPA diameter (mm) | 24.9±3.7 | 56 | 21.6±3.4 | 165 | P<0.001 |
| LPA diameter (mm) | 22.4±3.4 | 55 | 20.3±2.7 | 151 | P<0.001 |
| AAo diameter (mm) | 35.9±4.0 | 55 | 34.4±4.1 | 165 | 0.03 |
| DAo diameter (mm) | 25.1±3.1 | 55 | 25.1±2.7 | 152 | 0.97 |
| MPA/AAo | 0.90±0.19 | 56 | 0.81±0.13 | 165 | P=0.001 |
| MPA/DAo | 1.30±0.32 | 55 | 1.09±0.17 | 152 | P<0.001 |
Note:
*
M ± SE; others, M ± SD.
Abbreviations: CT, computed tomography; COPD, chronic obstructive pulmonary disease; PH, pulmonary hypertension; CRP, C-reactive protein; TG, triglyceride; MPA, main pulmonary artery; RPA, right pulmonary artery; LPA, left pulmonary artery; AAo, ascending aorta; DAo, descending aorta; M, mean; SE, standard error; SD, standard deviation.